The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial report on hospitalized cancer patients with COVID-19 from the National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).
 
Nicholas M. Mark
Employment - CTI BioPharma Corp (I); KenSci; Sound Life Sciences
Leadership - Sound Life Sciences
Stock and Other Ownership Interests - BioNTech; Bristol-Myers Squibb/Celgene; CTI BioPharma Corp (I); Forty Seven; Gilead Sciences; Moderna Therapeutics; Neoleukin Therapeutics; Novartis; Novartis; Pfizer; Vertex
Consulting or Advisory Role - Autolus; Presuna Inc.
 
Ana F. Best
No Relationships to Disclose
 
Alok A. Khorana
Honoraria - Anthos Therapeutics; Bayer; Halozyme; Janssen; Medscape; Nektar; Pfizer
Consulting or Advisory Role - Anthos Therapeutics; Bayer; Janssen; Pharmacyclics; Pharmacyte Biotech; Seagen
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Leap Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen; Seagen
 
Steven Pergam
Research Funding - Chimerix (Inst); Global Life Technologies (Inst)
Other Relationship - Sanofi Pasteur (Inst)
 
Grace E. Mishkin
No Relationships to Disclose
 
Melissa Bowman
No Relationships to Disclose
 
Andrea M. Denicoff
No Relationships to Disclose
 
Lawrence Rubinstein
No Relationships to Disclose
 
Lalitha Krishna Shankar
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Brian I. Rini
Leadership - MJH Life Sciences
Stock and Other Ownership Interests - PTC Therapeutics
Consulting or Advisory Role - 3D Medicines; Aravive; Arrowhead Pharmaceuticals; AVEO; Bristol-Myers Squibb; Corvus Pharmaceuticals; Eisai; GlaxoSmithKline; Merck; Pfizer; Shionogi; Surface Oncology; synthorx
Research Funding - Aravive (Inst); Arrowhead Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Dragonfly Therapeutics (Inst); Exelixis (Inst); Immunomedics (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); Surface Oncology (Inst); Taris (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer
 
Larissa A. Korde
No Relationships to Disclose